Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Bluebird Bio (NQ: BLUE)
87.26 USD  -2.46 (-2.74%)
Official Closing Price  /  Updated: 7:58 PM EST, Jan 24, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 749,600
Open 91.42
Bid (Size) 86.50 (1)
Ask (Size) 88.15 (1)
Prev. Close 89.72
Today's Range 86.75 - 91.42
52wk Range 71.42 - 163.43
Shares Outstanding 50,119,272
Dividend Yield N/A
Performance
YTD
+1.03%
+1.03%
1 Month
-3.62%
-3.62%
3 Month
+6.18%
+6.18%
6 Month
-37.56%
-37.56%
1 Year
-28.94%
-28.94%
Top News
More News
bluebird bio Announces Launch in Germany of ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do
bluebird bio, Inc. (Nasdaq: BLUE) announced the launch in Germany of ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene), a one-time gene therapy for patients 12 years and older with... Read More
from Business Wire News Releases
bluebird bio Announces Investor Events in January
bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will present at the following upcoming investor conferences in January: Read More
from Business Wire News Releases
More News
Read More
UPDATE 1-Novartis, GBT sickle cell drugs too expensive, draft U.S. report says
category companyNews
from Reuters: Company News
Novartis, GBT sickle cell drugs too expensive, draft U.S. report says
category companyNews
from Reuters: Company News
First Week of March 20th Options Trading For bluebird bio (BLUE)
category Stocks
from Market News Video
Analysts Forecast 14% Gains Ahead For The Holdings of BBH
category ETFs
from ETF Channel
Bull trend persists, S&P 500 digests powerful rally atop 20-day volatility bands
category BLUE , COMP , Markets/Exchanges , and 21 more.
from MarketWatch
FDA Puts GlaxoSmithKline's Blood Cancer Drug In the Fast Lane
category Market News , GSK , JNJ , and 2 more.
from Motley Fool
Thursday's ETF Movers: CQQQ, FBT
category ETFs
from ETF Channel
2 Biotech Stocks to Watch In 2020
category Market News , BLUE , VRTX , and 2 more.
from Motley Fool
Bluebird Bio Inc Shares Up 7.6% Since SmarTrend's Buy Recommendation (BLUE)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.